Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (51-60 of 420) with videos related to

Pageof 42
Sort By:
Immunity|August 4, 2021
Accelerated COVID-19 vaccine development: milestones, lessons, and prospectsKarin Bok, Sandra Sitar, Barney S Graham, et al.
Annual Review of Medicine|January 30, 2019
Structure-Based Vaccine Antigen DesignBarney S Graham, Morgan S A Gilman, Jason S McLellan
Journal of Virology|April 29, 2004
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV GPhilip J Budge, Yeqiang Li, Judy A Beeler, et al.
Plos One|January 12, 2016
Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-DependentKaitlyn M Morabito, Noam Erez, Barney S Graham, et al.
Annals of Internal Medicine|January 18, 2021
SARS-CoV-2 Vaccines: Much Accomplished, Much to LearnMark Connors, Barney S Graham, H Clifford Lane, et al.
Journal of Virology|May 27, 2011
Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopesJason S McLellan, Yongping Yang, Barney S Graham, et al.
The New England Journal of Medicine|February 15, 2023
Audio Interview: What to Expect from Covid-19 VaccinesEric J Rubin, Lindsey R Baden, Barney S Graham, et al.
The Journal of Infectious Diseases|December 7, 2016
Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya VirusAdam D DeZure, Nina M Berkowitz, Barney S Graham, et al.
European Journal of Immunology|February 11, 2014
Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responsesJie Liu, Shirley Cao, Gretchen Peppers, et al.
Journal of Virology|January 21, 2009
Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparitiesTracy J Ruckwardt, Kathryn L Bonaparte, Martha C Nason, et al.
Pageof 42

Showing results (51-60 of 420) with videos related to

Sort By:
Pageof 42
Immunity|August 4, 2021
Accelerated COVID-19 vaccine development: milestones, lessons, and prospectsKarin Bok, Sandra Sitar, Barney S Graham, et al.
Annual Review of Medicine|January 30, 2019
Structure-Based Vaccine Antigen DesignBarney S Graham, Morgan S A Gilman, Jason S McLellan
Journal of Virology|April 29, 2004
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV GPhilip J Budge, Yeqiang Li, Judy A Beeler, et al.
Plos One|January 12, 2016
Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-DependentKaitlyn M Morabito, Noam Erez, Barney S Graham, et al.
Annals of Internal Medicine|January 18, 2021
SARS-CoV-2 Vaccines: Much Accomplished, Much to LearnMark Connors, Barney S Graham, H Clifford Lane, et al.
Journal of Virology|May 27, 2011
Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopesJason S McLellan, Yongping Yang, Barney S Graham, et al.
The New England Journal of Medicine|February 15, 2023
Audio Interview: What to Expect from Covid-19 VaccinesEric J Rubin, Lindsey R Baden, Barney S Graham, et al.
The Journal of Infectious Diseases|December 7, 2016
Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya VirusAdam D DeZure, Nina M Berkowitz, Barney S Graham, et al.
European Journal of Immunology|February 11, 2014
Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responsesJie Liu, Shirley Cao, Gretchen Peppers, et al.
Journal of Virology|January 21, 2009
Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparitiesTracy J Ruckwardt, Kathryn L Bonaparte, Martha C Nason, et al.
Pageof 42